| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — |
| Net Income | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $0.84 | $0.59 | $2.12 | $3.02 | $0.64 | $0.44 |
| EPS (Diluted) | $0.83 | $0.58 | $2.10 | $2.97 | $0.63 | $0.43 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Total Assets | $5.3B | $3.9B | $3.8B | $3.4B | $3.0B | $2.4B |
| Current Assets | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.2B | $0.2B | — |
| Total Liabilities | $4.8B | $3.5B | $3.4B | $3.0B | $2.7B | $2.1B |
| Current Liabilities | — | — | — | — | — | — |
| Stockholders' Equity | $0.5B | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.0B | $0.0B | $0.1B | $0.1B | $-0.0B | $0.0B |
| Investing Cash Flow | $-0.3B | $-0.1B | $-0.3B | $-0.4B | $-0.5B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.2B | $0.1B | $0.0B | $0.3B | $0.6B | $0.1B |